TKO Group <TKO.N>: Bernstein cuts target price to $235 from $240
TKO•Related News
Core Scientific Q2 FY26 net loss widens to $1.16 billion; revenue rises to $164.2 million
CORZ•
GSK H1 FY26 profit attributable to shareholders rises to $2.91 billion; turnover increases to $21.49 billion
GSK•
IQVIA Q2 revenue beats estimates; outlook raised
IQV•
Tenet Healthcare Corp <THC.N>: Morgan Stanley raises target price to $274 from $254
THC•
Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 million
RGEN•